These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27780267)

  • 1. Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study.
    Govorov I; Löfgren S; Chaireti R; Holmström M; Bremme K; Mints M
    PLoS One; 2016; 11(10):e0164683. PubMed ID: 27780267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postpartum Hemorrhage in Women with von Willebrand Disease: Consider Other Etiologies.
    Kazi S; Arusi I; McLeod A; Malinowski AK; Shehata N
    J Obstet Gynaecol Can; 2022 Sep; 44(9):972-977. PubMed ID: 35569789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study.
    Lim MY; Rodgers GM; Branch DW; Simonsen SE
    Haemophilia; 2024 Mar; 30(2):470-477. PubMed ID: 38343098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage.
    Majluf-Cruz K; Anguiano-Robledo L; Calzada-Mendoza CC; Hernández-Juárez J; Moreno-Hernández M; Domínguez-Reyes VM; Figueroa-Torres AG; Gomez-Rosas P; Arreola-Diaz R; García-Lee MT; Ricardo-Moreno MT; Sosa-Camas RE; Garcia-Chavez J; Vela Ojeda J; Isordia-Salas I; Majluf-Cruz A
    Haemophilia; 2020 Jan; 26(1):97-105. PubMed ID: 31823446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.
    Stoof SC; van Steenbergen HW; Zwagemaker A; Sanders YV; Cannegieter SC; Duvekot JJ; Leebeek FW; Peters M; Kruip MJ; Eikenboom J
    Haemophilia; 2015 Jul; 21(4):505-12. PubMed ID: 25688733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.
    Machin N; Ragni MV
    Blood Adv; 2020 Jul; 4(14):3234-3238. PubMed ID: 32692849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage.
    Chee YL; Townend J; Crowther M; Smith N; Watson HG
    Haemophilia; 2012 Jul; 18(4):593-7. PubMed ID: 22335463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis.
    James AH; Konkle BA; Kouides P; Ragni MV; Thames B; Gupta S; Sood S; Fletcher SK; Philipp CS
    Haemophilia; 2015 Jan; 21(1):81-7. PubMed ID: 25333737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory monitoring during pregnancy and post-partum hemorrhage in women with von Willebrand disease.
    O'Brien SH; Stanek JR; Kaur D; McCracken K; Vesely SK
    J Thromb Haemost; 2020 Mar; 18(3):604-608. PubMed ID: 31808272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.
    Reynen E; James P
    Semin Thromb Hemost; 2016 Oct; 42(7):717-723. PubMed ID: 27648611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of the Von Willebrand disease PREVENT trial.
    Ragni MV; Machin N; James AH; Seaman CD; Malec LM; Kessler CM; Konkle BA; Kouides PA; Neff AT; Philipp CS; Brooks MM
    Thromb Res; 2017 Aug; 156():8-13. PubMed ID: 28577390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postpartum Hemorrhage in Patients with Type 1 von Willebrand Disease: A Systematic Review.
    Pierce-Williams RAM; Makhamreh MM; Blakey-Cheung S; Gao Z; Al-Kouatly HB
    Semin Thromb Hemost; 2022 Mar; 48(2):219-228. PubMed ID: 34749402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining international practices in the management of pregnant women with von Willebrand disease.
    Lavin M; Sánchez Luceros A; Kouides P; Abdul-Kadir R; O'Donnell JS; Baker RI; Othman M; Haberichter SL;
    J Thromb Haemost; 2022 Jan; 20(1):82-91. PubMed ID: 34661341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate.
    Iorio A; James P; Ma A; Srivastava A
    J Thromb Haemost; 2024 Oct; 22(10):2739-2744. PubMed ID: 38950781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical use of Haemate® P in von Willebrand disease: a 25-year retrospective observational study.
    Miesbach W; Krekeler S; Wolf Z; Seifried E
    Thromb Res; 2015 Mar; 135(3):479-84. PubMed ID: 25595881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstetric bleeding among women with inherited bleeding disorders: a retrospective study.
    Hawke L; Grabell J; Sim W; Thibeault L; Muir E; Hopman W; Smith G; James P
    Haemophilia; 2016 Nov; 22(6):906-911. PubMed ID: 27704714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.